FDA approves Truvada for preventing HIV infection

The Food and Drug Administration on Monday approved Truvada for prevention of HIV infection in HIV-negative people who are at high risk of contracting the disease, the first time a drug has been approved for reducing that risk. The approval follows on the heels of three studies published last week in the New England Journal of Medicine which showed that daily use of the drug could reduce transmission of the virus by as much as 75% in heterosexual couples. The drug has also been shown to be effective in gay couples.

bridging finance mortgage